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Background: Clinical practice protocols should consider both the psychological criteria
related to a patient’s satisfaction as a consumer of health services and the economic
criteria to allocate resources efficiently. An electroconvulsive therapy (ECT) program was
implemented in our hospital to treat psychiatric patients. The main objective of this study
was to determine the cost associated with the ECT sessions implemented in our hospital
between 2008 and 2014. A secondary objective was to calculate the cost of sessions
that were considered ineffective, defined as those sessions in which electrical convulsion
did not reach the preset threshold duration, in order to identify possible ways of saving
money and improving satisfaction among psychiatric patients receiving ECT.
Methods: A descriptive analysis of the direct health costs related to ECT from the
perspective of the public health system between 2008 and 2014 was performed using
a retrospective chart review. All of the costs are in euros (2011) and were discounted
at a rate of 3%. Based on the base case, a sensitivity analysis of the changes of those
variables showing the greatest uncertainty was performed.
Results: Seventy-six patients received 853 sessions of ECT. The cumulative cost of
these sessions was €1409528.63, and 92.9% of this cost corresponded to the hospital
stay. A total of €420732.57 (29.8%) was inefficiently spent on 269 ineffective sessions.
A sensitivity analysis of the economic data showed stable results to changes in the
variables of uncertainty.
Conclusion: The efficiency of ECT in the context outlined here could be increased by
discerning a way to shorten the associated hospital stay and by reducing the number of
ineffective sessions performed.
Keywords: mental disorders, electroconvulsive therapy, patient satisfaction, costs and cost analysis, costs of
health care, direct service costs
INTRODUCTION
An economic evaluation of health care is needed because financial resources are limited and must
therefore be allocated in the most efficient way. In the field of health, such evaluations would prove
useful because they would help decision-makers identify the best ways to allocate resources, which
would be immensely helpful for making decisions both at the general level of health by Health
Administration and at a more specific level by health staff (Drummond et al., 2015).
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In recent years, there has been an ongoing discussion
regarding the concept of “patient-centered care”; this concept
considers allowing patients to play an important role in making
decisions about their own health. Furthermore, clinical practice
decisions should consider not only factors related to the
effectiveness and efficiency of a treatment but also the perspective
of the patient, specifically his/her satisfaction with the treatment
process (Mira and Aranaz, 2000).
The subject of this work is the more specific case of the
psychiatric patient, for whom satisfaction with the care process
is evaluated by questionnaires fulfilled by both the patient and
his/her relatives. These questionnaires have identified the most
important items that influence a positive perception of health
service by the patient. Those items include (1) the competence
of care professionals, (2) being given complete information
about the diagnosis and treatment, (3) patient involvement in
the treatment plan, and (4) providing an explanation for the
usefulness of the hospitalization (Berghofer et al., 2001; Blenkiron
and Hammill, 2003; Gani et al., 2011; Fernandez-Carbonell et al.,
2012).
Electroconvulsive therapy (ECT) is currently considered an
effective treatment for patients with severe psychiatric disorders,
especially for severe depressive disorders (mainly psychotic
depression), some cases of acute mania and schizophrenic
disorders (Bernardo, 1999; American Psychiatric Association
Committee on Electroconvulsive Therapy, 2001; Rodriguez-
Jimenez, 2015a). ECT consists of the application of electrical
stimulation to the brain in order to trigger a generalized seizure.
It is accepted that the optimal response to ECT is related to
the duration of the triggered seizures, although there is no
consensus for what the limit should be. ECT is administered
two or three times per week for the acute phase of the disease,
until between 6 and 12 sessions have been administered;
usually, acute phase treatment is performed on an in-patient
basis (Sackeim, 1991; Bernardo, 1999; American Psychiatric
Association Committee on Electroconvulsive Therapy, 2001;
Ding and White, 2002; Gonzalez et al., 2007; Perestelo-Perez
et al., 2013; Rodriguez-Jimenez, 2015a). After completing the
acute phase, the patients may possibly continue to receive
additional ECT sessions as part of a continuation cycle or
a maintenance cycle, depending on whether these sessions
are applied during the first 6 months after the acute phase
(continuation cycle to prevent relapses) or after 6 months
(maintenance cycle to prevent recurrence; American Psychiatric
Association Committee on Electroconvulsive Therapy, 2001).
However, it is a more common practice to indiscriminately
call them continuation/maintenance (Rodriguez-Jimenez,
2015a).
An ECT program was implemented in our hospital to expand
treatment alternatives beyond drug treatment. Regarding the
Spanish health care system, economic evaluations focused on
ECT are scarce, and to the best of our knowledge, there has
been no evaluation of the economic impact of the so-called
ineffective sessions. The aim of this work was to identify possible
ways of optimizing the use of health and economic resources,
which in turn would improve patient perception of the treatment
process.
Specifically, the main objective of this study was to
determine the cost associated with the sessions of ECT that
were implemented in our hospital between 2008 and 2014.
A secondary objective was to calculate the cost of sessions that
were considered ineffective, defined as those sessions in which
the electrical convulsion did not reach the preset threshold
duration.
MATERIALS AND METHODS
A retrospective chart review of all patients who had received at
least one ECT session from April 2008 to December 31st, 2014
while admitted at the Mental Health Service in a 752-beds tertiary
hospital was conducted. No exclusion criteria were considered.
A partial economic evaluation consisting of a description of
costs was done from the perspective of the public health system.
Only direct health costs were considered for our analysis, which
include those costs incurred by the health system as a direct result
of the disease (Oliva et al., 2015).
The cost of a standard ECT session was calculated as the
product of health resources employed (measured in natural units
and obtained from the routine records of each ECT session) for
their unitary prices (measured in monetary units of the 2011
base year, discounted at a rate of 3%). The cost of an ECT
session for each patient and each given cycle (the acute phase
versus the continuation/maintenance phase) was also calculated.
For this purpose, the cost of the hospital stay associated with
ECT, the cost of the time spent by the medical staff, the
consumables and drugs employed, and the cost of the purchase
of the ECT equipment were considered, with the following
observations:
Hospital Stay
Information about the costs of a 24-h hospital stay at the
Department of Mental Health was expressed in euros per day
and was provided by the Control Service Management of our
hospital. The total hospital stay was obtained from patients’
charts. For the purpose of this study, three different time periods
of hospitalization were defined: pre-ECT, ECT, and post-ECT.
The total days of admittance to the Mental Health Department
were calculated by subtracting the date of hospital discharge
from the date of hospital admittance. The days attributable to
the ECT period were calculated by subtracting the date of the
last ECT from the date of the first ECT session and then adding
2 days to account for anesthetic evaluation. If the patient had
been transiently discharged during the weekend holidays, then
these days were subtracted from the days attributable to the ECT
period.
Medical Staff and Nursing
Information about the salary (expressed in euros per minute
of time spent by the professionals involved) was provided by
our Service Management Control. To calculate the cost per staff
caused by this activity, a typical ECT session was considered to be
30 min of time consuming activity for the following professionals:
three physicians (two from the Mental Health Department and
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one from the Anesthesiology Department) and three nurses (two
from the Anesthesiology Department and one from the Mental
Health Department). The time spent by other professionals, such
as assistants and orderlies, was not considered for this analysis.
Drugs and Consumables
Information concerning the acquisition cost of drugs and
consumables used in an ECT session according to our protocol
was provided by the Hospital Pharmacy and Management
Control Services.
Equipment
The equipment with which the ECT was applied was ABBOT
SPECTRUM brand (model 5000Q, EQ-ELMED class), and it was
acquired in December, 2007 for €23500. This information was
provided by the Management Control Service. The equivalent
annual cost (at an interest rate of 3% and considering a useful
life of 10 years) was calculated since its acquisition, and this cost
was divided by the number of annual sessions of ECT conducted
in the study period.
The cost of all of the ECT sessions was calculated by adding the
cost of each session received by all of the patients. The cost of the
ineffective sessions was calculated in the same way, i.e., by adding
the cost of each ineffective session of all patients. Following
the established protocol of the Mental Health Department,
ECT sessions were considered ineffective when an electrical
convulsion lasted less than 20 s. A more conservative approach
was taken to assess the cost of ineffective sessions, considering
those sessions lasting 20 or more seconds after re-stimulation
as not ineffective, and by also not considering titration sessions
because titration sessions are used to determine the minimum
threshold electrical charge for each patient in each acute phase
cycle and are, therefore, associated with a higher percentage of
ineffective sessions.
In addition, these cost calculations were repeated considering
25 s, not 20 s, as the minimal duration for an acceptable electrical
convulsion because 25 s is the most frequently cited limit in the
psychiatric literature.
A sensitivity analysis was conducted, considering variations
from the base case, in terms of personnel costs, the discount rate
and the average cost per hospital stay.
Statistical Plan
This is a descriptive study in which continuous variables
were described using means and standard deviations, and the
qualitative variables were described using absolute and relative
frequencies.
Ethics Statement
This chart review study was approved by the Ethics Committee
and Clinical Research of our hospital.
RESULTS
During the implementation of the ECT program at our hospital
from April 2008 to December 2014, 76 patients received at least
one ECT session, accounting for 853 sessions. Table 1 shows
the characteristics of the patients and the ECT sessions. For 13
sessions (1.5%), the information about seizure duration was not
available, and the sessions were classified as effective to avoid bias
favoring the economic burden of ineffective sessions (our second
objective).
The cost of a standard ECT session was €1667.35. The
distribution of the costs derived from a standard ECT session
is shown in Table 2, where it can be seen that the hospital stay
represented the main economic burden.
The cumulative cost of all of the 853 ECT sessions
administered was €1409528.63 (Table 3). Of those, €420732.57
(29.8%) was inefficiently employed for performing 269 ineffective
sessions, defined as when the electrical seizure did not reach
20 s. Following our conservative approach, 31 titration sessions
lasting less than 20 s with an associated cost of €52165.90
were excluded from the ineffective group, and there were
also 62 sessions lasting more than 20 s after re-stimulation
with an associated cost of €98671.55. Therefore, using a more
conservative approach €269865.42 (19.1%) were determined to
be used inefficiently.
By pure logic, setting 25 s as the lower limit for an adequate
electrical convulsion would increase the number of inefficient
sessions (426, Table 1) and the cost associated to inefficient
sessions (48.3%, Table 3).
As stated above, the hospital stay represented the largest
portion of the total cost (92.9%; Table 3). Before it had been
decided to treat the patients with ECT (pre-ECT period), they
had been admitted for a median of 15.5 days (interquartile
range 5–25.25), representing a cost of €891564.38. Considering
this time course, the cost of treating psychiatric patients would
have increased by more than 60%, specifically from €1409528.63
TABLE 1 | Clinical and demographic characteristics of patients
undergoing electroconvulsive therapy.
N %
Patients 76 –
Age (years) 52 ± 16 –
Sex (female) 46 60.5
Diagnostic indication for ECT
Affective disorder without psychotic symptoms 27 35.5
Affective disorder with psychotic symptoms 17 22.4
Psychotic disorder 30 39.5
Others 2 2.6
Clinical outcome
GCI-I = 1 (very much improved) 22 21.8
GCI-I = 2 (much improved) 40 39.6
GCI-I = 3 (minimally improved) 28 27.7
GCI-I = 4 (no change) 11 10.9
ECT sessions 853 –
Sessions with convulsion lasting <20” 269/853 31.5
Sessions with convulsion lasting <20” re-stimulated 164/269 61.0
Re-stimulated sessions with convulsion lasting ≥20” 73/164 44.5
Sessions with convulsion lasting <25” 426/853 49.9
ECT, electroconvulsive therapy; GCI-I, Global Clinic Impression-Improvement scale.
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TABLE 2 | Average cost of a standard electroconvulsive therapy session
(2008–2014)a.
Unitary costs Health resources Average cost (%)
HOSPITAL STAYb 665.11 2.34 1529.76 (91.8)
STAFFc 74.70 (4.5)
Physician salary 0.50 90 45.26 (2.7)
Nurse salary 0.33 90 29.44 (1.8)
EXPENDABLES 35.33 (2.1)
Nasal O2-cannula
and CO2-sensor
with female luer
adapter
connectiond
19.11 1 19.11 (1.1)
Sensor for level of
sedation and
consciousness in
anesthetic
processes
15.94 1 15.94 (1.0)
3-piece syringe,
concentric catheter
cone 50 ml
0.17 1 0.17 (<0.1)
2-piece syringe,
eccentric luer cone
20 ml
0.05 1 0.05 (<0.1)
2-piece syringe,
eccentric luer cone
10 ml
0.03 1 0.03 (<0.1)
2-piece syringe,
eccentric luer cone
5 ml
0.02 2 0.04 (<0.1)
EQUIPMENTe 20.61 1 20.61 (1.2)
DRUGS 6.95 (0.4)
Propofol 1%
200 mg
2.01 1 2.01 (0.1)
Remifentanil 1 mg 2.98 1 2.98 (<0.2)
Atropine 1 mg 0.10 1 0.10 (<0.1)
Succinylcholine
100 mg
0.31 1 0.31 (<0.1)
Dexketoprofen
50 mg
0.57 1 0.57 (<0.1)
Saline solution
0,9% 100 ml
0.44 1 0.44 (<0.1)
Sodium chloride
solution 0.9% for
irrigation, sterile
500 Ml
0.56 1 0.56 (<0.1)
TOTAL 1667.35 (100)
aAll costs are in euros of 2011 and are discounted at a rate of 3%. bCost per
hospital stay is expressed in euro/day. cStaff costs are expressed in euros/minute.
dThese calculations correspond to the first session of each cycle because the nasal
cannula is re-used in every electroconvulsive therapy session for the same patient.
eCost of equipment has been obtained by calculating the Annual Equivalent Cost
(at an interest rate of 3% and useful life of 10 years) and dividing it by the number
of annual sessions of electroconvulsive therapy.
to €2301093.01. In contrast, during the ECT period, patients
had 149 days of weekend discharges, resulting in a savings of
€89102.57 (5.9%).
The sensitivity analysis of the economic data shows
stable results for variations of the uncertainty variables
(Table 4).
DISCUSSION
The main results of our work are, first, that the hospital stay is
responsible for more than 90% of the total costs attributed to
ECT and, second, that there are a large number of ineffective
ECT sessions, which implies that almost 30% of the economic
resources had been inefficiently used.
Regarding the economic evaluation of ECT, there have
been studies that have reported a cost-effectiveness analysis
or cost description analysis in which ECT is compared with
pharmacotherapy (Aziz et al., 2005; Greenhalgh et al., 2005)
or other techniques such as repetitive transcranial magnetic
stimulation (Kozel et al., 2004; McLoughlin et al., 2007; Knapp
et al., 2008; Vallejo-Torres et al., 2014), as well as studies focusing
on continuation/maintenance programs (Bonds et al., 1998;
McDonald et al., 1998; Aziz et al., 2005; Odeberg et al., 2008;
Rodriguez-Jimenez et al., 2015b). In general, these studies have
concluded that ECT is cost-effective.
Based on this premise, we have conducted a purely descriptive
study of the direct costs that our hospital has incurred after
implementing an ECT program. According to our results, the cost
of a standard ECT session was €1667.35. In our environment,
Vallejo-Torres et al. (2014) found a cost of €737, but they only
considered the costs of staff, materials, equipment, tests, and
drugs in their analysis, and they did not include the cost of the
hospital stay. If they had included this cost, then the cost of a
standard ECT session would rise to €1475 (referred to in 2013
euros and ascribing 2 days of stay for each ECT session), a figure
very similar to what we found.
TABLE 3 | Total cost of electroconvulsive therapy sessions (2008–2014).
Total cost of ECT sessions 1409528.63
Hospital stay 1308884.56
Staff 54643.19
Expendables 25841.87
Equipment 15076.25
Drugs 5082.89
Total cost for sessions with electric convulsion lasting <20” 420732.57
Total cost for sessions with electric convulsion lasting <25” 681068.03
ECT, electroconvulsive therapy. All costs are expressed in constant euros of 2011
and discounted at a rate of 3%.
TABLE 4 | Sensitivity analysis.
Base case 1409528.63
Staff, 20 min 1388629.26
Staff, 40 min 1430429.30
Discount rate 0% 1549554.62
Discount rate 5% 1348736.29
10% increase in hospital stay cost 1540417.06
10% decrease in hospital stay cost 1278640.15
20% increase in hospital stay cost 1671305.52
20% decrease in hospital stay cost 1147751.70
Total cost of electroconvulsive therapy sessions (2008–2014). All costs are
expressed in constant euros of 2011.
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In view of our results, we propose two ways to improve
the efficiency of the ECT: reducing the number of ineffective
sessions and shortening the hospital stay of the patients. By
attaining these objectives, two advantages would be expected:
first, an improvement in the efficiency of the treatment itself and,
second, a consideration of the patients’ preferences in line with
the above mentioned “patient-centered care.” By implementing
these actions, patients would be allowed to return to their homes
and resume their activities earlier, which, in turn, would be
perceived with great satisfaction both for the patients and their
relatives.
Regarding the objective of reducing the number of ineffective
sessions, we found that the percentage of funds invested in
ineffective sessions (those lasting less than 20 s; Bertolin-Guillen
et al., 2006; Ramirez-Segura and Ruiz-Chow, 2013) ranged
between 29.8 and 19.1%, as assessed either in a less or more
conservative approach, respectively. A clear limitation of this
assessment is the assumption that the clinical efficacy of ECT
depends solely on the electrical length of the evoked seizure,
when there is no evidence that this assumption is true (Fear
et al., 1994; Geretsegger et al., 1998; Sackeim, 1999; Azuma
et al., 2007; Bauer et al., 2009; Stewart, 2012; Martinez-Amoros
et al., 2014). In fact, different values for the lower limit of
the electrical convulsion can be found in the literature: 15 s
(Gonzalez et al., 2007), 20 s (Bertolin-Guillen et al., 2006;
Ramirez-Segura and Ruiz-Chow, 2013), 25 s (Nguyen et al.,
1997; Dogan et al., 2011; Gombar et al., 2011; Hizli Sayar
et al., 2014; Martinez-Amoros et al., 2014), and 26 s (Wang
et al., 2011). These data preclude us from directly comparing
the percentage of sessions that were considered ineffective. To
perform an indirect comparison with other authors who used
propofol as a hypnotic and to consider the lower limit of efficacy
at 25 s, we re-analyzed our data after establishing the 25 s limit.
Using this approach, our percentage of ineffective sessions would
rise to 50%, a value that is much lower than that found by
Martinez-Amoros et al. (2014; 82.9%) but much higher than
that found by Nguyen et al. (1997; 4.2%). This huge disparity
in the percentage of ineffective sessions could be explained by
the small number of sessions held by these authors: 35 sessions
(Martinez-Amoros et al., 2014) and 22 sessions (Nguyen et al.,
1997).
However, despite the considerable number of so-called
ineffective sessions that have taken place, the efficacy of ECT
in our patients measured by the CGI-I was 61.4%. This finding
was obtained as a result of the sum of cycles of treatment whose
clinical development had been “very much improved” and “much
improved,” as shown in Table 1.
Our percentage of ineffective sessions (19.1%, conservative
estimate) suggests that there is room for improvement in
the performance of the ECT sessions. This improvement
would include modification of the guidelines of psychiatry and
anesthesiology, which is beyond the scope of this work.
Regarding the second aspect of our investigation, we did a
thorough analysis of the costs associated with ECT and found
that micro-costs (i.e., those costs associated with consumables,
equipment and drugs) could be ignored in future studies because
they represent a practically negligible percentage of the total
cost (less than 4%). Conversely, the hospital stay represented the
highest percentage of economic burden; therefore, any strategy
to save costs should be aimed at reducing the hospital stay of the
patients.
We found an average delay of 2 weeks from hospital
admittance to inclusion in the ECT program. It was not the aim
of this work to study the costs associated to this pre-ECT period,
but they were definitely significant costs assumed by the Health
System and a clear target for some cost-saving measures. This
delay occurs because it is routine clinical practice of our Mental
Health Department physicians to exhaust drug therapy before
entering the patients into an ECT program.
To reduce the hospital stay, one possibility could be to
exhaust drug therapy in an out-patient setting for those patients
whose clinical condition would permit out-patient management;
therefore, in the event that they must be admitted to receive
ECT, it could be performed soon after admittance. For those
patients whose clinical condition would not allow for out-patient
management before drug alternatives had been exhausted, ECT
could be considered earlier than when it is currently indicated.
In either case, the length of the hospital stay would be shortened
(Kramer, 1990; Chan et al., 2006).
Another way to reduce the hospital stay would be by
increasing weekend discharges. Until now, this option has been
scarcely adopted. We did not review the full clinical aspects
of the patients; thus, based on our data, it is impossible to
determine whether more weekend discharges were possible
for clinical reasons, which represents a clear limitation to
our statement. However, weekend discharges in our Mental
Health Department are not a standard protocol; therefore,
we do believe that there is a potential to save costs in
this way.
Another way to reduce the duration of hospital stays would
be to assess the performance of ambulatory ECT (Kramer, 1990;
Chan et al., 2006; Rodriguez-Jimenez, 2015a) instead of the
traditional custom of performing ECT in an in-patient manner
for the entire duration of the corresponding cycle. Selected
patients, such as those not requiring ongoing psychiatric care,
could benefit the obvious advantages of ambulatory treatment,
such as staying at home with their relatives for as long as possible,
which, in turn, could significantly contribute to improving their
clinical condition and perhaps would also improve the patients’
perception of and satisfaction with their psychiatric treatment.
Ambulatory ECT is already a real option in our context (Lopez
Villaescusa et al., 2011; Rodriguez-Jimenez, 2015a).
This work has several limitations. Some of the limitations have
been exposed above, for example, the assumption that the clinical
efficacy of ECT depends solely on the electrical length of the
seizure, not having analyzed the causes behind the delay between
the hospital admission and the decision to indicate ECT, and not
explaining the limited number of weekend hospital discharges
of the patients. In addition to these limitations, this work has
the general limitations of any retrospective review (i.e., a lack of
information in medical records) and a more specific economic
limitation, that is, that the average costs of the hospital stay (cost
per diem) were used to assess the cost of the stay (Drummond
et al., 2015).
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CONCLUSION
Electroconvulsive therapy efficiency could increase by reducing
the number of ineffective sessions and by reducing hospital
stay. Whether a reduction in the number of ineffective sessions
could be attained by modifying the anesthesiologist-psychiatric
protocol deserves future research, as well as a reduction
in hospital stay by encouraging hospital permissions and
ambulatory ECT. On the basis of these assumptions were
true, the patients’ perceptions of their treatment process would
be improved for three main reasons: clinically, because their
treatment efficacy would be increased; psychologically, because
their hospital admittance would be shortened in time or even
avoided; and economically, because by applying the concept of
opportunity cost, the economic savings could be employed to
benefit the patients even if they are unaware of these savings.
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